News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AbbVie (ABBV) Drops Legal Action In EU Drug Secrecy Case


4/4/2014 6:05:07 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Reuters) - AbbVie, one of the two U.S. companies trying to stop Europe's drugs regulator from releasing previously secret clinical trials data, said on Thursday it had withdrawn lawsuits against the watchdog.

The decision follows a move by the London-based European Medicines Agency (EMA) to accept a new set of redacted documents submitted by AbbVie, along with the company's rationale for removing certain commercially confidential information.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Bloomberg
Read at Seeking Alpha
Read at News Release


comments powered by Disqus
AbbVie
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES